Physician profile
Nora Takla
NPI 1962464271
$357.90
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4.18 · 2020: $26.60 · 2021: $3.82 · 2022: $31.81 · 2023: $206 · 2024: $85.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $100.45 | 2023 | Dornier Thulio, Sonablate |
| Sumitomo Pharma America, INC. | $50.56 | 2023 | Orgovyx, Gemtesa |
| Abbvie INC. | $49.59 | 2024 | |
| Urogen Pharma, INC. | $19.93 | 2024 | |
| Travere Therapeutics, INC. | $19.46 | 2019-2021 | |
| Edap Technomed INC | $19.25 | 2023 | |
| Myriad Genetic Laboratories, INC. | $18.75 | 2023 | Prolaris |
| Coloplast Corp | $16.82 | 2022 | |
| Angiodynamics, INC. | $16.67 | 2023 | Nanoknife |
| Procept Biorobotics Corporation | $16.29 | 2024 | Aquabeam System |
| Neotract INC. | $15.14 | 2020 | |
| Profound Medical Corp. | $14.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Takla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.